The Global Wound Care Biologics Market Size is expected to reach USD 2.16 Billion by 2032, at a CAGR of 5.6% during the forecast period 2022 to 2032. Wound Care Biologics represent an innovative approach to healing complex and chronic wounds by utilizing biological materials to enhance the regenerative process. These advanced therapies harness the power of naturally occurring substances such as growth factors, cytokines, and extracellular matrices, which promote cell proliferation, angiogenesis, and tissue remodeling.